elevate research properties

What elevate research properties does

Elevate Research Properties is a New York-based life science real estate company that develops, manages, and operates premier laboratory and research facilities for life science tenants. The company is a wholly-owned subsidiary of Taconic Partners, a private equity firm, and is responsible for all activities across Taconic's life science real estate portfolio including acquisitions, debt and equity capital markets, design, development and construction, leasing, tenant community engagement, operations, and property management. Elevate's portfolio currently consists of three facilities: West End Labs at 125 West End Avenue, Hudson Research Center at 619 West 54th Street, and Iron Horse Labs.

The company serves life science organizations — including biotechnology, pharmaceutical, medical device, and related research entities — that require specialized laboratory infrastructure with specific HVAC, utility, and compliance capabilities that traditional commercial real estate typically does not provide. Its core offering is purpose-built or adapted wet-lab and research space delivered as a turnkey managed facility, enabling tenants to focus on scientific activity rather than real estate operations.

Elevate generates revenue through recurring commercial real estate leases, with pricing negotiated on a case-by-case basis and not publicly disclosed. Its go-to-market is enterprise field sales conducted through direct outreach by senior executives (Matthew Weir and Michael Adelstein, using tacon.com email domains) to prospective life science tenants. The corporate website is minimal and currently displays a 'Website Coming Soon' notice, with full portfolio detail pages listed as forthcoming — indicating the digital presence is still being built out.

Name

elevate research properties

Legal name

Elevate Research Properties

Website

https://elevateresearchproperties.com

Company type

Private

Operating status

Operating

Short description

Elevate Research Properties develops, manages, and operates premier life science real estate facilities across three New York City assets, serving biotechnology, pharmaceutical, and research tenants. It is a wholly-owned subsidiary of private equity firm Taconic Partners.

Ownership category

akta.pro rank

Product category

Life Science Real Estate

NAICS

Real Estate Property Managers (53131)

SIC

Operators Of Nonresidential Buildings (6512), Real Estate Agents & Managers (For Others) (6531)

akta.pro primary industry

Life Sciences/Laboratory Property Management (BPAJAGAL)

akta.pro secondary industry

Life Sciences/Lab Tenant Representation (BPAJALAG)

Keywords

• Life science real estate
• Research facility leasing
• Lab space development
• Commercial lab buildings
• Biotech real estate

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Operations, Infrastructure, Personnel, Marketing or Sales, Technology or R&D

Revenue model

1. Commercial Real Estate Leasing: Revenue generated through leasing laboratory and research space to life science companies. The company builds, manages, and operates premier life science real estate facilities, generating income through commercial lease arrangements with tenants in the life sciences sector.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Elevate Research Properties develops and manages purpose-built life science real estate facilities, providing specialized laboratory and research spaces within New York City. The company leases and operates buildings engineered to meet the stringent infrastructure requirements of life science tenants, including biotech, pharmaceutical, and academic research organizations. Operating as a wholly-owned subsidiary of Taconic Partners, it holds and manages a portfolio of research properties across Manhattan.

Product overview

Elevate Research Properties is a life science real estate company that builds, manages, and operates premier life science real estate facilities in strategic core markets. The company operates as a wholly-owned subsidiary of Taconic Partners and is responsible for all activities in the life science portfolio including acquisitions, debt and equity capital markets, design, development and construction, leasing, tenant community engagement, operations, and property management. The portfolio consists of three distinct life science facilities: West End Labs (125 West End Avenue), Hudson Research Center (619 West 54th Street), and Iron Horse Labs.

Differentiator

Problem solved

Functional benefit

Products and services

• West End Labs
• Hudson Research Center
• Iron Horse Labs

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators1 record

Recent moves4 records

Expansion highlights3 records

Broad incumbents

• Healthpeak Properties: Healthpeak Properties is a diversified REIT with a sizable life science segment alongside medical/outpatient office. While not purely life science, its lab/outpatient portfolio overlaps with Elevate's tenant base and asset category, providing a broad incumbent comparable.
• Trammell Crow Company (CBRE): Trammell Crow is a major commercial real estate developer (owned by CBRE) with an active life science development practice. It represents a large-scale incumbent competitor for lab development opportunities and institutional tenants relative to Elevate's focused NYC platform.

Direct peers

• King Street Properties: King Street Properties is a privately held developer and operator of life science real estate, with significant holdings in the Cambridge/Boston market. It is comparable to Elevate in operating model and tenant focus, though more concentrated in a different geographic cluster.
• Alexandria Real Estate Equities: Alexandria is the largest publicly traded REIT focused on life science real estate, operating mission-critical lab and office facilities for tenants including biotech, pharma, and government research organizations. It is the benchmark comp for any specialized life science operator including Elevate, with a far larger and more diversified cluster footprint.
• Breakthrough Properties: Breakthrough Properties is a privately held life science real estate developer backed by a major institutional investor, focused on developing and operating Class A lab facilities in top-tier clusters. It competes with Elevate for similar tenant relationships and development opportunities.
• BioMed Realty (Blackstone): BioMed Realty is a major life science real estate owner/operator now owned by Blackstone, with a portfolio concentrated in top-tier innovation clusters. It directly competes with Elevate for institutional life science tenants and acquisition opportunities, with a much larger capital base.
• Longfellow Real Estate Partners: Longfellow is a privately held real estate investment and development firm focused exclusively on life science facilities across major US innovation markets. It is a direct competitor to Elevate in serving biotech and pharma tenants with specialized lab space.
• IQHQ (Beacon Capital Partners): IQHQ is a specialized life science real estate developer/owner focused on premium lab and innovation campuses in core biotech clusters. It is a close comparable to Elevate in vertical integration, tenant focus, and premium asset positioning.

Regional players

• Deerfield Management: Deerfield is a healthcare investment firm with life science real estate and operating company holdings concentrated primarily in NYC's East Side (including the CureLife campus). It is a regional competitor for NYC life science tenants and real estate opportunities relative to Elevate.

Others

• New York City Economic Development Corporation (NYCEDC) - Life Science Initiatives: NYCEDC drives NYC life science cluster strategy and incentives through programs like LifeSci NYC, and influences demand, zoning, and capital flows into the NYC lab market that Elevate operates in. Not a competitor but a key ecosystem participant shaping Elevate's market.

Market position

Strengths1 record

Weaknesses4 records

Competitive moat4 records

Key risks4 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/elevate-research-properties

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about elevate research properties